Physician profile
John Crantford
NPI 1225358005
$6,543.84
in general payments reported to CMS, 2019-2025
10 companies · $537 in 2025
The $537 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,778 · 2020: $843 · 2021: $1,461 · 2022: $868 · 2023: $824 · 2024: $231 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,592.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $2,875.56 | 2019-2022 | |
| Sientra, INC. | $1,166.00 | 2020-2022 | |
| Abbvie INC. | $1,073.21 | 2023-2025 | Natrelle Saline-Filled Breast Implants |
| Tepha INC | $417.73 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $293.37 | 2019-2023 | |
| Mentor Worldwide LLC | $217.25 | 2019-2023 | Mentor Memorygel Resterilizable Gel Sizer, Monocryl |
| Galderma Laboratories, L.P. | $166.01 | 2019-2024 | |
| Motiva USA, LLC | $157.43 | 2025 | |
| Sanara Medtech INC. | $151.66 | 2025 | Celleraterx |
| Pacira Pharmaceuticals Incorporated | $25.62 | 2025 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Crantford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.